Peginterferon-α-2a (40kD) Plus RibavirinA Review of its Use in the Management of Chronic Hepatitis C

被引:0
作者
Gillian M. Keating
Monique P. Curran
机构
[1] Adis International Limited,
来源
Drugs | 2003年 / 63卷
关键词
Chronic Hepatitis; Sustained Virological Response; Virological Response; Sustained Virological Response Rate; Early Virological Response;
D O I
暂无
中图分类号
学科分类号
摘要
引用
收藏
页码:701 / 730
页数:29
相关论文
共 154 条
[1]  
Davis GL(2001)Treatment of chronic hepatitis C: combination therapy permanently eradicates the virus in at least 40% of patients BMJ 323 1141-2
[2]  
Lauer GM(2001)Hepatitis C virus infection N Engl J Med 345 41-52
[3]  
Walker BD(2002)Pegylated interferons for the treatment of chronic hepatitis C infection Clin Ther 24 1363-83
[4]  
Luxon BA(2001)Disease management program for hepatitis C: a team approach to setting goals Dis Manage Health Outcomes 9 431-9
[5]  
Grace M(1997)National Institutes of Health Consensus Development Conference Panel statement: management of hepatitis C Hepatology 26 2S-10S
[6]  
Brassard D(1999)Treatment strategies for chronic hepatitis C: update since the 1997 National Institutes of Health Consensus Development Conference J Gastroenterol Hepatol 14 S12-8
[7]  
Koff RS(2002)Course and outcome of hepatitis C Hepatology 36 S21-9
[8]  
Powell DW(2002)Introduction to therapy of hepatitis C Hepatology 36 S114-20
[9]  
Abramson BZ(2001)PEGylated interferons: what role will they play in the treatment of chronic hepatitis C? Curr Gastroenterol Rep 3 30-7
[10]  
Balint JA(2001)Development of pegylated interferons for the treatment of chronic hepatitis C Biodrugs 15 419-29